Institutional Readiness for Management of Moderna COVID-19 Vaccine in Trusts

Ian Allen, Pharmacy Quality Assurance Regional Specialist (NW), North West Pharmaceutical Quality AssurancePublished Last updated See all updates

Must read guidance for Chief Pharmacists and others in Trusts on the Moderna COVID-19 Vaccine

Purpose

The attachment below outlines the medicines management responsibilities of Chief Pharmacists for Mass Vaccination in Trust sites, and provides supporting guidance and resources in relation to:

  • Safe storage and distribution, including temperature controlled storage.
  • Oversight of vaccine handling and preparation, including management of shelf life reduction processes following defrosting

The document aims to promote consistency of practice by providing flow diagrams outlining a stepwise approach to implementing Pharmacy processes to receive, store and issue vaccines, and to oversee vaccine handling processes by clinical staff.

Attachments

Other handling content for Trusts

Other COVID-19 vaccines resources

What to do if you still have questions

If you still have questions you can get in touch with us. However, please first read our service remit; and if you still think we can help, use the email address below.

We're supporting healthcare professionals in England with pharmaceutical aspects of the COVID-19 vaccination programme; read our service remit to find out more.
If you're a healthcare professional in England, get in touch with us if you still have questions

Change history

  1. Correction to fridge storage temperature range in process flow 1
  1. Vaccine has full UK marketing authorisation from 01/04/2021. Link to SPC and PIL added.
  1. Published